Reticulate bodies from a type C and elementary bodies from a type L2 strain of Chlamydia trachomatis were isolated and used as antigens in an enzyme-linked immunosorbent assay (ELISA). Results obtained for human sera with these two antigens used in the ELISA were compared with each other and with results obtained for the same sera by the micro-immunofluorescence test. Negative control populations included cloistered nuns and children with respiratory infections. Populations at risk for chlamydial infection consisted of 42 men with nongonococcal urethritis attending a sexually transmitted diseases clinic and 42 college women who had contact with men with nongonococcal urethritis. ELISAs done with the two antigens were equivalent to each other and to the microimmunofluorescence test in the ability to predict the presence or absence of infection. None of the tests had high predictive values for the men with urethritis. However, the negative predictive value of both the micro-immunofluorescence test and the elementary body ELISA was 0.92 for the college women. Such serological tests may be of value in screening selected populations for subclinical infections with C. trachomatis.
Infection with Chlamydia trachomatis is now the most common sexually transmitted disease (STD) (3, 5) . Although many men (17) and women (18) who are infected with this organism are asymptomatic, considerable evidence is accumulating that such infections are not benign. Included in the disease syndromes attributed to C. trachomatis are urethritis, cervicitis, salpingitis, proctitis, conjunctivitis, and pneumonia (3, 5, 16) . In addition, subclinical infections appear to be a major cause of infertility in women (6) .
Unfortunately, diagnosis of chlamydial infections in most clinical settings is difficult, expensive, or both. Isolation of the organism in tissue culture remains the diagnostic method of choice. However, recovery rates are affected by the manner in which a clinical specimen is obtained, transported, and stored (10, 12) and the method used to infect tissue culture cells (12, 21) . Consequently, reliable cultures are generally available only in large medical centers with extensive experience in tissue culture methodology. Other diagnostic techniques, such as direct antigen detection in clinical specimens (19) , may offer considerable theoretical promise but require further evaluation in a clinical setting.
The identification of chlamydial antibodies in serum or secretions lacks the specificity of tissue culture identification but may on occasion provide useful information (23, 24) . The standard complement fixation test is not sufficiently sensitive for the diagnosis of genital tract infection (15, 23) . However, the micro-immunofluorescence (micro-IF) test of Wang and Grayston (22) (23) (24) , which uses chlamydial elementary bodies (EBs) as a test antigen, has been shown to be both sensitive and specific for the detection of chlamydial antibodies. Similar immunofluorescence tests that use purified reticulate bodies (RBs) (26) or infected cells (13) as the test antigen have also been described.
More recently, detection of chlamydial antibodies by both radioimmunoassay and enzymelinked immunosorbent assay (ELISA) has been described (2, 8, 9, 20 (26) . After the cells were disrupted by sonication followed by differential centrifugation (500 x g for 10 min and 30,000 x g for 30 min, respectively), they were partially purified by centrifugation through a 30o Renograffin (methylglucamine diatrizoate, 76% for injection; E. R. Squibb & Sons, New York, N.Y.) cushion at 22,000 x g for 40 min. They were then fixed in 6% Formalin in Hanks balanced salt solution, pelleted, resuspended in 0.02% Formalin in phosphate-buffered saline (PBS) (4 mM KH2PO4, 16 mM Na2HPO4, 115 mM NaCl, pH 7.3), and stored at 4°C until used.
EBs from strain L2/434 were harvested from McCoy cells 48 h after infection and subjected to differential centrifugation as described above. The pellet (yield from three 150-cm2 flasks) was then suspended in 25 ml of 30% (vol/vol) Percoll (Pharmacia Inc., Uppsala, Sweden)-10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-145 mM NaCl (pH 7.4) and centrifuged at 30,000 x g for 30 min at 4°C (SS-34 angle head rotor; Du Pont Co., Wilmington, Del.). Two bands were resolved in the self-generating Percoll gradient. The band at the bottom of the gradient consisted of purified EBs and about 5% RBs, as determined by electron microscopy. The band of chiamydial particles was diluted sixfold in HBS (10 mM HEPES-145 mM NaCl [pH 7.4]) and centrifuged at 30,000 x g for 30 min at 4°C. The EB pellet was washed again in HBS, suspended in HBS containing 0.05% Formalin, and stored at -70°C.
EB and RB protein concentrations were determined by the method of Bradford (1), with bovine serum albumin used as a standard after samples were boiled for 1 min in 0.1% sodium dodecyl sulfate.
Attempts to purify RBs in Percoll instead of Renograffin were unsuccessful, presumably due to osmotic lysis.
Chlamydial serology. The micro-IF test was performed with EB antigens from representative strains of all known immunotypes of C. trachomatis (except Ba) as described by Wang et al. (24) and with an RB antigen from strain TW-3 as described by Yong et al. (26) .
The RB and EB ELISAs were performed with standard ELISA technology (25) . Based on protein content, RBs from strain TW-3 or EBs from strain L2/ 434 were diluted to the appropriate concentration in 0.5 M Na2CO3 (pH 9.6), and 0.2 ml of this suspension was used to coat each well of a 96-well polystyrene microtiter plate (Dynatech Laboratories Inc., Alexandria, Va.). After incubation for 18 h at room temperature, the antigen suspension was aspirated, and each well was washed three times with PBS (pH 7.3)-0.05% (vol/vol) Tween 20 (Sigma Chemical Co., St. Louis, Mo.) (PBST).
A 0.3-ml amount of PBST, 0.5% with respect to bovine serum albumin, was added to each well, and the plates were incubated for 1 h at room temperature. Each well was then washed once with 0.3 ml of PBST, and 0.2 ml of a 1:100 dilution of serum in PBST was added to each well. Incubation was carried out at 37°C for 1 h, the serum was aspirated from each well, and each well was washed three times with 0.3 ml of PBST. To each well was then added 0.2 ml of a 1:1,000 dilution in PBST of alkaline phosphatase-conjugated goat anti-human immunoglobulin G (IgG) (Sigma). After further incubation for 1 h at 37°C, the conjugate was removed by aspiration, and each well was washed five times with 0.3 ml of PBST. Next, 0.2 ml of pnitrophenyl phosphate (1 mg/ml)-50 mM Na2CO3-1 mM MgCl (pH 9.8) was added to each well, and incubation was continued at 37°C for 30 to 40 min. A well containing a strongly reactive control serum was monitored until an absorbance of 1.0 at 405 nm was reached. The reaction was then stopped with the addition of 25 p.l of 5 N NaOH to each well, and the absorbance at 405 nm was determined in a spectrophotometer.
A control well without antigen was run for each serum tested, as were control wells without serum (both with and without antigen) for each plate tested.
Chlamydial cultures. Isolation of C. trachomatis from clinical specimens was done as described by Kuo et al. (7) Urethral cultures for C. trachomatis and serum were obtained from 42 men attending an inner-city STD clinic for whom a diagnosis of nongonococcal urethritis (NGU) was made. The criteria employed for a diagnosis of NGU were: presence of a urethral discharge, dysuria, or both; gram-stained material from an endourethral swab that revealed >4 polymorphonuclear leukocytes per field and no gram-negative intracellular diplococci at 400x magnification; and a urethral culture negative for Neisseria gonorrhoeae. All patients were in good health except for urethritis.
In addition, 42 college women referred to a student health service because of sexual contact with a man with NGU were evaluated for evidence of chlamydial infection. All were asymptomatic and in good health. Evaluation included chlamydial serology and endocervical cultures for chlamydiae. The sensitivity, specificity, and predictive value of serological tests for these groups were calculated by standard methods (4 Fig. 1 . The four sera used in this experiment were used to standardize both the RB and EB ELISAs. Similar curves were obtained with the EB antigen, except that it required two to four times more EBs (based on protein concentration) than RBs to produce the same absorbance with a given serum.
Antigen excess was not observed at 100 ,ug of protein per ml with either EBs or RBs. Antigen concentrations of 10 pLg/ml for EBs and 2.5 ,ug/ ml for RBs were chosen for use in subsequent experiments. They gave equivalent absorbances with the high-titer sera shown in Fig. 1 (23) .
On the other hand, quite different results were obtained in the college women we evaluated. Their background seropositivity rate (24% for the EB ELISA in culture-negative women) was similar to that reported for adults in general. This may reflect fewer sexual partners over their lifetime and thus an overall lower exposure rate than that usually seen in patients attending STD clinics (11, 15) . However, the prevalence of infection (31%) was consistent with their having had recent contact with men with NGU. This combination of factors resulted in positive and negative predictive values of 0.63 and 0.96, respectively. Admittedly, this is a highly selected population. In unselected college women with a prevalence of infection closer to 5% (11) , the predictive value of a positive serological test would be much lower. However, the negative predictive value of the test would remain high so long as its sensitivity remained high (4) .
Although additional studies in larger population groups are needed to define the diagnostic role of chlamydial serological tests, it would seem that in selected groups of patients a negative test by micro-IF or ELISA may be as effective at excluding a diagnosis of infection as a negative culture, given that the sensitivity of the latter is only about 90% (15) . Approximately 20% of men with a first episode of chlamydial NGU are seronegative by micro-IF (23) , and thus a negative serology test in men with NGU would not be helpful. A similar false-negative rate has not been reported in women, although some women would also be expected to be seronegative shortly after acquiring a first chlamydial infection. No attempt was made in the present study to distinguish between source and secondary contacts. Some of the NGU contacts were presumably secondary, yet only 1 of the 13 culture-positive women was seronegative by either micro-IF or the EB ELISA. Whether the relative numbers of seronegative, culture-positive NGU contacts would increase with a larger sample size is unknown.
In spite of these problems in interpretation, serological testing may prove sufficiently convenient and cost effective to be of value in the initial screening of selected populations in whom there is a low background of seropositivity. Examples could include middle-class women who are pregnant or seeking contraceptives for the first time. A positive serological test would only indicate exposure, not active infection, and would be an indication for further evaluation (i.e., culture). A negative serological test, on the other hand, would provide reasonable evidence that subclinical infection was not present unless it had been very recently acquired. The importance of diagnosing subclinical infections in pregnant women is primarily to prevent transmission of the infection to their infants (16) , whereas in sexually active young women early diagnosis and treatment may prevent later salpingitis and infertility (5, 6) . In populations of women in whom the prevalence of infection and seropositivity is high, culture remains the only practical means for screening.
